APA (7th ed.) Citation

Nappi, C., Megna, R., Zampella, E., Volpe, F., Piscopo, L., Falzarano, M., . . . Klain, M. (2025). External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging, 52(8), 2867-2874. https://doi.org/10.1007/s00259-025-07124-2

Chicago Style (17th ed.) Citation

Nappi, Carmela, et al. "External Validation of a Predictive Model for Post-treatment Persistent Disease by 131I Whole-body Scintigraphy in Patients with Differentiated Thyroid Cancer." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 8 (2025): 2867-2874. https://doi.org/10.1007/s00259-025-07124-2.

MLA (9th ed.) Citation

Nappi, Carmela, et al. "External Validation of a Predictive Model for Post-treatment Persistent Disease by 131I Whole-body Scintigraphy in Patients with Differentiated Thyroid Cancer." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 8, 2025, pp. 2867-2874, https://doi.org/10.1007/s00259-025-07124-2.